IOL Chemicals and Pharmaceuticals Limited (BOM:524164)
India · Delayed Price · Currency is INR 169.55
+5.75 (3.51%)
At close: Aug 21, 2026
BOM:524164 Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 49,768 | 21,354 | 17,964 | 21,222 | 16,608 | 20,770 | |
Market Cap Growth | 73.01% | 18.87% | -15.35% | 27.78% | -20.04% | -35.74% |
Enterprise Value | 49,119 | 21,226 | 17,708 | 21,198 | 16,855 | 18,047 |
Last Close Price | 169.55 | 72.75 | 60.38 | 70.50 | 54.50 | 67.30 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 29.61 | 15.51 | 17.77 | 15.79 | 11.94 | 12.39 |
Forward PE | 21.06 | 14.55 | 10.75 | 9.60 | 10.45 | - |
PS Ratio | 1.97 | 0.92 | 0.86 | 1.00 | 0.75 | 0.95 |
PB Ratio | 2.77 | 1.19 | 1.06 | 1.32 | 1.10 | 1.49 |
P/TBV Ratio | 2.79 | 1.20 | 1.07 | 1.33 | 1.11 | 1.50 |
P/FCF Ratio | 120.42 | 51.67 | - | 135.95 | - | - |
P/OCF Ratio | 23.22 | 9.96 | 10.06 | 7.32 | 13.58 | 22.32 |
PEG Ratio | - | 4.37 | 0.46 | 0.46 | 0.46 | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.95 | 0.92 | 0.85 | 0.99 | 0.76 | 0.83 |
EV/EBITDA Ratio | 15.77 | 7.87 | 8.74 | 9.24 | 7.48 | 6.98 |
EV/EBIT Ratio | 21.42 | 11.20 | 13.57 | 12.64 | 9.36 | 8.35 |
EV/FCF Ratio | 118.85 | 51.36 | - | 135.80 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.08 | 0.08 | 0.07 | 0.02 | 0.05 | 0.03 |
Debt / EBITDA Ratio | 0.43 | 0.50 | 0.58 | 0.14 | 0.35 | 0.17 |
Debt / FCF Ratio | - | 3.28 | - | 2.10 | - | - |
Net Debt / Equity Ratio | -0.04 | -0.04 | -0.05 | -0.07 | 0.04 | -0.05 |
Net Debt / EBITDA Ratio | -0.21 | -0.24 | -0.46 | -0.48 | 0.27 | -0.29 |
Net Debt / FCF Ratio | - | -1.57 | 2.64 | -7.05 | -0.68 | 1.26 |
Asset Turnover | - | 0.93 | 0.90 | 1.00 | 1.11 | 1.22 |
Inventory Turnover | - | 4.15 | 3.61 | 3.78 | 4.24 | 4.49 |
Quick Ratio | - | 1.19 | 1.22 | 1.13 | 1.20 | 1.19 |
Current Ratio | - | 1.78 | 1.89 | 2.00 | 2.02 | 2.11 |
Return on Equity (ROE) | - | 7.90% | 6.13% | 8.62% | 9.60% | 12.64% |
Return on Assets (ROA) | - | 4.77% | 3.53% | 4.91% | 5.65% | 7.56% |
Return on Invested Capital (ROIC) | 9.86% | 8.50% | 6.17% | 8.09% | 9.21% | 14.37% |
Return on Capital Employed (ROCE) | - | 10.00% | 7.40% | 10.00% | 11.50% | 14.90% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 3.38% | 6.45% | 5.63% | 6.33% | 8.38% | 8.07% |
FCF Yield | 0.83% | 1.93% | -1.94% | 0.74% | -5.39% | -2.90% |
Dividend Yield | 0.59% | 1.38% | 1.32% | 1.42% | 1.47% | 1.19% |
Payout Ratio | - | 21.32% | 23.23% | 21.83% | 16.89% | 21.01% |
Buyback Yield / Dilution | -0.13% | - | - | - | - | -0.64% |
Total Shareholder Return | 0.46% | 1.38% | 1.32% | 1.42% | 1.47% | 0.55% |